
SEARCH
QUICKLINKS AND VIEW OPITONS
Measles vaccine recommended by WHO increased mortality in females 2-fold notes Peter Aaby, DMSc
Posted by .(JavaScript must be enabled to view this email address)
Thursday, March 28, 2019 11:00 am Email this article
In this 23-second video clip, Peter Aaby, DMSc, founder of the Bandim Health Project in West Africa, notes that they found that a new measles vaccine that was recommended by the WHO in 1989 increased the death rate in female infants 2-fold.
He notes that, had it been implemented, the new measles vaccine would have caused an additional 500,000 female deaths in Africa.
Peter Aaby is credited for the discovery of non-specific effects of vaccines – i.e. effects of vaccines, which go beyond the specific protective effects against the targeted diseases.
In 1978, Peter Aaby, DMSc established the Bandim Health Project, a Health and Demographic Surveillance System site in Guinea-Bissau in West Africa, which he has run ever since.
Peter Aaby’s group has also found that…
https://www.bandim.org/research/non-specific-effects
“The live attenuated vaccines, measles vaccine, oral polio vaccine, smallpox vaccine and BCG vaccine, seem to confer more general protection against a broad range of pathogens.”
“However, the non-live vaccines like diphtheria-tetanus-pertussis vaccine (DTP) have been associated with increased susceptibility to other pathogens, particularly in females.”
That is, live-attenuated vaccines reduce the overall risk of death, whereas non-live vaccines increase the overall risk of death.
The vaccine story is more complicated than what the CDC is telling us.
Articles on the same subject can be found here:
COMMENTS
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.